In this study, we aimed to investigate the potential effect of oxaliplatin/capecitabine- and cisplatin/5-fluorouracil-based neoadjuvant therapy on the expression of PD-L2 in cancer cells and TILs in neoadjuvantly treated AEG using immunohistochemistry. Here, PDCD1LG2 is linked to cancer.